Umb Bank, N.A. Invitae Corp Transaction History

Umb Bank, N.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 10, 2023	SELL	$1.71 - $3.61 $613 - $1,295	-359 Reduced 31.27%	789 $1,000
Q3 2022 Oct 13, 2022	SELL	$1.9 - $8.63 $577 - $2,623	-304 Reduced 20.94%	1,148 $3,000
Q2 2022 Jul 20, 2022	BUY	$2.13 - $9.01 $764 - $3,234	359 Added 32.85%	1,452 $4,000
Q1 2022 Apr 22, 2022	BUY	$6.28 - $15.59 $4,954 - $12,300	789 Added 259.54%	1,093 $9,000
Q4 2021 Feb 09, 2022	BUY	$14.7 - $28.67 $4,468 - $8,715	304 New	304 $5,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

Stay updated on Umb Bank, N.A. with notifications on news.